Abnormalities in large-scale brain network dynamics in late-life depression with suicidal ideation: an EEG microstate analysis.

Yicheng Lin, Zhangying Wu, Min Zhang, Gaohong Lin, Yijie Zeng, Jingyi Lao, Huarong Zhou, Ben Chen, Qiang Wang, Danyan Xu, Mingfeng Yang, Yuping Ning, Xiaomei Zhong
Author Information
  1. Yicheng Lin: From The Geriatric Neuroscience Center, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China (Y. Lin, Wu, Zhang, G. Lin, Zeng, Lao, Zhou, Chen, Wang, Xu, Yang, Ning, Zhong); the First School of Clinical Medicine, Southern Medical University, Guangzhou, China (Ning); the Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou, China (Ning, Zhong).
  2. Zhangying Wu: From The Geriatric Neuroscience Center, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China (Y. Lin, Wu, Zhang, G. Lin, Zeng, Lao, Zhou, Chen, Wang, Xu, Yang, Ning, Zhong); the First School of Clinical Medicine, Southern Medical University, Guangzhou, China (Ning); the Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou, China (Ning, Zhong).
  3. Min Zhang: From The Geriatric Neuroscience Center, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China (Y. Lin, Wu, Zhang, G. Lin, Zeng, Lao, Zhou, Chen, Wang, Xu, Yang, Ning, Zhong); the First School of Clinical Medicine, Southern Medical University, Guangzhou, China (Ning); the Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou, China (Ning, Zhong).
  4. Gaohong Lin: From The Geriatric Neuroscience Center, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China (Y. Lin, Wu, Zhang, G. Lin, Zeng, Lao, Zhou, Chen, Wang, Xu, Yang, Ning, Zhong); the First School of Clinical Medicine, Southern Medical University, Guangzhou, China (Ning); the Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou, China (Ning, Zhong).
  5. Yijie Zeng: From The Geriatric Neuroscience Center, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China (Y. Lin, Wu, Zhang, G. Lin, Zeng, Lao, Zhou, Chen, Wang, Xu, Yang, Ning, Zhong); the First School of Clinical Medicine, Southern Medical University, Guangzhou, China (Ning); the Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou, China (Ning, Zhong).
  6. Jingyi Lao: From The Geriatric Neuroscience Center, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China (Y. Lin, Wu, Zhang, G. Lin, Zeng, Lao, Zhou, Chen, Wang, Xu, Yang, Ning, Zhong); the First School of Clinical Medicine, Southern Medical University, Guangzhou, China (Ning); the Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou, China (Ning, Zhong).
  7. Huarong Zhou: From The Geriatric Neuroscience Center, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China (Y. Lin, Wu, Zhang, G. Lin, Zeng, Lao, Zhou, Chen, Wang, Xu, Yang, Ning, Zhong); the First School of Clinical Medicine, Southern Medical University, Guangzhou, China (Ning); the Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou, China (Ning, Zhong).
  8. Ben Chen: From The Geriatric Neuroscience Center, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China (Y. Lin, Wu, Zhang, G. Lin, Zeng, Lao, Zhou, Chen, Wang, Xu, Yang, Ning, Zhong); the First School of Clinical Medicine, Southern Medical University, Guangzhou, China (Ning); the Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou, China (Ning, Zhong).
  9. Qiang Wang: From The Geriatric Neuroscience Center, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China (Y. Lin, Wu, Zhang, G. Lin, Zeng, Lao, Zhou, Chen, Wang, Xu, Yang, Ning, Zhong); the First School of Clinical Medicine, Southern Medical University, Guangzhou, China (Ning); the Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou, China (Ning, Zhong).
  10. Danyan Xu: From The Geriatric Neuroscience Center, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China (Y. Lin, Wu, Zhang, G. Lin, Zeng, Lao, Zhou, Chen, Wang, Xu, Yang, Ning, Zhong); the First School of Clinical Medicine, Southern Medical University, Guangzhou, China (Ning); the Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou, China (Ning, Zhong).
  11. Mingfeng Yang: From The Geriatric Neuroscience Center, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China (Y. Lin, Wu, Zhang, G. Lin, Zeng, Lao, Zhou, Chen, Wang, Xu, Yang, Ning, Zhong); the First School of Clinical Medicine, Southern Medical University, Guangzhou, China (Ning); the Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou, China (Ning, Zhong).
  12. Yuping Ning: From The Geriatric Neuroscience Center, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China (Y. Lin, Wu, Zhang, G. Lin, Zeng, Lao, Zhou, Chen, Wang, Xu, Yang, Ning, Zhong); the First School of Clinical Medicine, Southern Medical University, Guangzhou, China (Ning); the Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou, China (Ning, Zhong) ningjeny@126.com lovlaugh@163.com.
  13. Xiaomei Zhong: From The Geriatric Neuroscience Center, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China (Y. Lin, Wu, Zhang, G. Lin, Zeng, Lao, Zhou, Chen, Wang, Xu, Yang, Ning, Zhong); the First School of Clinical Medicine, Southern Medical University, Guangzhou, China (Ning); the Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China (Ning); the Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou, China (Ning, Zhong) ningjeny@126.com lovlaugh@163.com.

Abstract

BACKGROUND: Patients with late-life depression (LLD) with suicidal ideation (SI) often have more explicit suicide plans, and suicide attempts among older adults are more highly lethal than in other age groups. Increasing evidence suggests that people with SI in depression exhibit abnormal brain network connectivity; however, the relationship between suicidal ideation in LLD and brain network dynamics is still unclear.
METHODS: We recruited patients with LLD and SI (LLD-SI), patients with LLD without SI (LLD-NSI), and age-matched healthy older adults. We collected 64-channel resting state electroencephalography (EEG) recordings of all participants and used microstate analysis to explore large-scale brain network dynamics.
RESULTS: We included 33 patients with LLD-SI, 29 patients with LLD-NSI, and 31 controls. We observed abnormal microstate parameters in the LLD-SI group, characterized by higher duration ( = 0.04), occurrence ( = 0.009), and contribution ( = 0.001) of microstate C (reflecting activity of the salience network), compared with the LLD-NSI group, as well as higher occurrence ( = 0.03) and contribution ( = 0.009) of microstate C compared with the control group. Furthermore, transition probabilities from microstate class A to D ( = -0.466, = 0.04) and class D to A ( = -0.506, = 0.02) (involving coupling and sequential activation of auditory and executive control network) were negatively correlated with completion time of Stroop Colour and Word Test Part C (a neuropsychological test of executive function) in the LLD-SI group.
LIMITATIONS: The sample size was relatively small, the cross-sectional nature of this study prohibited exploring the causal relationship between abnormal microstate dynamics and suicidal ideation, and we did not include medication-naive patients with first-episode LLD.
CONCLUSION: The study reveals altered microstate dynamics among patients with LLD-SI, compared with patients with LLD-NSI and controls. Our findings suggest that microstate dynamics could serve as potential neurobiomarkers for identifying SI in LLD.

References

  1. Trends Cogn Sci. 2011 Oct;15(10):483-506 [PMID: 21908230]
  2. Am J Psychiatry. 2021 Dec;178(12):1119-1128 [PMID: 34645274]
  3. Brain Behav Immun Health. 2022 Oct 04;26:100523 [PMID: 36267834]
  4. Annu Rev Clin Psychol. 2016;12:307-30 [PMID: 26772209]
  5. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62 [PMID: 14399272]
  6. J Psychiatr Res. 2012 Feb;46(2):226-32 [PMID: 22024486]
  7. World J Psychiatry. 2022 Jan 19;12(1):187-203 [PMID: 35111588]
  8. Psychol Med. 2020 May;50(7):1214-1223 [PMID: 31144614]
  9. J Affect Disord. 2012 Oct;140(2):193-9 [PMID: 22464009]
  10. Brain Topogr. 2024 Mar;37(2):181-217 [PMID: 37162601]
  11. Neuropsychopharmacology. 2012 Feb;37(3):697-706 [PMID: 21993207]
  12. Eur Arch Psychiatry Clin Neurosci. 2024 Feb;274(1):207-225 [PMID: 37421444]
  13. Nat Rev Neurosci. 2015 Jan;16(1):55-61 [PMID: 25406711]
  14. J Affect Disord. 2024 Feb 1;346:57-63 [PMID: 37949236]
  15. Transl Psychiatry. 2021 Jan 12;11(1):38 [PMID: 33436537]
  16. Eur Neuropsychopharmacol. 2020 Nov;40:85-98 [PMID: 32778367]
  17. Neuropsychiatr Dis Treat. 2024 Jun 06;20:1201-1210 [PMID: 38860214]
  18. Front Psychiatry. 2019 Aug 09;10:548 [PMID: 31474881]
  19. JAMA Psychiatry. 2025 Jan 1;82(1):12-21 [PMID: 39476073]
  20. Biol Psychiatry. 2002 Aug 1;52(3):193-204 [PMID: 12182926]
  21. Psychiatry Res. 2020 Mar;285:112713 [PMID: 31810745]
  22. Am J Geriatr Psychiatry. 2023 Nov;31(11):905-915 [PMID: 37271652]
  23. Nat Commun. 2020 Jun 18;11(1):3089 [PMID: 32555168]
  24. Brain Topogr. 2021 Jul;34(4):442-460 [PMID: 33871737]
  25. Neurosci Biobehav Rev. 2015 Feb;49:105-13 [PMID: 25526823]
  26. Neuroimage. 2021 Jan 1;224:117393 [PMID: 32971266]
  27. J Affect Disord. 2018 Jan 15;226:92-99 [PMID: 28968564]
  28. Dev Cogn Neurosci. 2018 Jun;31:58-66 [PMID: 29742488]
  29. Ann Neurol. 1990 Apr;27(4):428-37 [PMID: 2353798]
  30. Neuroimage. 2019 Jul 1;194:82-92 [PMID: 30902640]
  31. J Am Geriatr Soc. 2007 Jul;55(7):1090-4 [PMID: 17608884]
  32. Clin Neurophysiol. 2021 Nov;132(11):2861-2869 [PMID: 34600244]
  33. J Affect Disord. 2023 Apr 1;326:216-224 [PMID: 36736791]
  34. Annu Rev Clin Psychol. 2009;5:363-89 [PMID: 19327033]
  35. Psychol Med. 2023 Jul;53(9):3837-3848 [PMID: 35257645]
  36. J Psychiatr Res. 2017 Apr;87:71-80 [PMID: 28017917]
  37. Psychol Med. 2013 Oct;43(10):2129-42 [PMID: 23298821]
  38. Biol Psychiatry. 2015 Aug 15;78(4):224-30 [PMID: 25861700]
  39. Front Hum Neurosci. 2020 Nov 13;14:585766 [PMID: 33281585]
  40. Am J Psychiatry. 2009 Aug;166(8):845-8 [PMID: 19651746]
  41. Brain Struct Funct. 2010 Jun;214(5-6):655-67 [PMID: 20512370]
  42. Brain Connect. 2017 Dec;7(10):671-682 [PMID: 28938855]
  43. J Geriatr Psychiatry Neurol. 2010 Sep;23(3):171-84 [PMID: 20430976]
  44. Brain Topogr. 2021 May;34(3):297-305 [PMID: 33709259]
  45. Clin Neurophysiol. 2023 Dec;156:272-280 [PMID: 37749014]
  46. Neuroscientist. 2014 Dec;20(6):652-64 [PMID: 24622818]
  47. Neuroimage. 2010 Oct 1;52(4):1162-70 [PMID: 20188188]
  48. Neuroimage. 2018 Oct 15;180(Pt B):577-593 [PMID: 29196270]
  49. J Affect Disord. 2019 Feb 15;245:545-552 [PMID: 30439679]
  50. World J Psychiatry. 2024 Jan 19;14(1):128-140 [PMID: 38327889]
  51. Int Psychogeriatr. 2023 Aug;35(8):421-431 [PMID: 33118918]
  52. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Feb;5(2):213-221 [PMID: 31901436]

MeSH Term

Humans
Male
Suicidal Ideation
Female
Aged
Electroencephalography
Nerve Net
Brain
Middle Aged
Depression

Word Cloud

Created with Highcharts 10.0.0microstate=patients0LLDnetworkdynamicsSILLD-SIsuicidalbrainLLD-NSIgroupdepressionideationabnormalCcomparedlate-lifesuicideamongolderadultsrelationshipEEGanalysislarge-scalecontrolshigher04occurrence009contributioncontrolclassD-0executivestudyBACKGROUND:PatientsoftenexplicitplansattemptshighlylethalagegroupsIncreasingevidencesuggestspeopleexhibitconnectivityhoweverstillunclearMETHODS:recruitedwithoutage-matchedhealthycollected64-channelrestingstateelectroencephalographyrecordingsparticipantsusedexploreRESULTS:included332931observedparameterscharacterizedduration001reflectingactivitysaliencewell03Furthermoretransitionprobabilities46650602involvingcouplingsequentialactivationauditorynegativelycorrelatedcompletiontimeStroopColourWordTestPartneuropsychologicaltestfunctionLIMITATIONS:samplesizerelativelysmallcross-sectionalnatureprohibitedexploringcausalincludemedication-naivefirst-episodeCONCLUSION:revealsalteredfindingssuggestservepotentialneurobiomarkersidentifyingAbnormalitiesideation:

Similar Articles

Cited By